Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
Recruiting · NCT05164263 · Registry updated 2026-01-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 4 | 2026-01-22 | NCT05164263 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Getz Pharma | 8 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Agha Khan univeristy hospital | Nairobi | Kenya | 1 |
| Kabul University of Medical Sciences(KUMS) | Kabul | Afghanistan | 1 |
| Lagos University Teaching Hospital | Lagos | Nigeria | 1 |
| National hospital Sri Lanka | Colombo | Sri Lanka | 1 |
| NHK | Kandy | Sri Lanka | 1 |
| Umar Diabetes Foundation | Islamabad | Pakistan | 1 |